Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
13.7% with Wegovy In key secondary endpoints, Zepbound was superior to Wegovy across all weight reduction targets and waist circumference reduction nd For the primary endpoint, participants treated with Zepbound achieved an average weight reduction of 20.2% compared to 13.7% with Wegovy at 72 weeks using the treatment-regimen estimand, 1 a 47% greater relative weight loss
That level of confidence is rare in the industry and signals that the company believes its protocols and support structure actually deliver results
Recent diet trends have significantly influenced public health by introducing both positive and negative impacts
Your diet directly dictates your comfort level on GLP-1 medications
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors
doi: 10.1021/jm9909645 100 BuckleySTBkdalTAVeggeAMaarbjergSJPykeCAhnfelt-RnneJet al
